Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Drug Resistance

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 16 articles: HTML format

Single Articles

January 2026
1. HOWIE RL, Sharma S, Kyle JL, Rubis AB, et al
   Serogroup Switching in Neisseria meningitidis with Dual Antibiotic Resistance.
   N Engl J Med. 2026;394:199-201.
   PubMed    
   
   
   December 2025
2. PEARL A, Karaba SM, Uhlemann AC
   Contact Precautions for MRSA and Vancomycin-Resistant Enterococcus.
   N Engl J Med. 2025;393:2475-2477.
   PubMed    
   
   
   June 2025
3. HOEFER A, Seth-Smith H, Palma F, Schindler S, et al
   Corynebacterium diphtheriae Outbreak in Migrant Populations in Europe.
   N Engl J Med. 2025;392:2334-2345.
   PubMed     Abstract available
   
   
   April 2025
4. MONTO AS, Kuhlbusch K, Bernasconi C, Cao B, et al
   Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
   N Engl J Med. 2025;392:1582-1593.
   PubMed     Abstract available
   
   
   January 2025
5. GUGLIELMETTI L, Khan U, Velasquez GE, Gouillou M, et al
   Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
   N Engl J Med. 2025;392:468-482.
   PubMed     Abstract available
   
   
   August 2024
6. O'BRIEN KS, Arzika AM, Amza A, Maliki R, et al
   Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.
   N Engl J Med. 2024;391:699-709.
   PubMed     Abstract available
   
   
   
7. GOLDMANN D, Rajan S, Udayakumar K
   Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach.
   N Engl J Med. 2024;391:681-685.
   PubMed    
   
   
   
8. MAITLAND K, Walker AS
   Why Was the Azithromycin "for Life" Trial Necessary?
   N Engl J Med. 2024;391:760-762.
   PubMed    
   
   
   June 2024
9. LIEBERMAN NAP, Reid TB, Cannon CA, Nunley BE, et al
   Near-Universal Resistance to Macrolides of Treponema pallidum in North America.
   N Engl J Med. 2024;390:2127-2128.
   PubMed    
   
   
   May 2024
10. WAGENLEHNER FM, McGovern PC, Moeck G
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection. Reply.
    N Engl J Med. 2024;390:1938-1939.
    PubMed    
    
    
    
11. MANESH A, Varghese GM, Paterson DL
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1938.
    PubMed    
    
    
    
12. VAN OS W, Zeitlinger M
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1937-1938.
    PubMed    
    
    
    
13. LANINI S, Cai T, Tascini C
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1937.
    PubMed    
    
    
    February 2024
14. WAGENLEHNER FM, Gasink LB, McGovern PC, Moeck G, et al
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:611-622.
    PubMed     Abstract available
    
    
    
15. STRONG N, Meeks G, Sheth SA, McCullough L, et al
    Neurovascular Complications of Iatrogenic Fusarium solani Meningitis.
    N Engl J Med. 2024;390:522-529.
    PubMed     Abstract available
    
    
    September 2023
16. MORELLO W, Baskin E, Jankauskiene A, Yalcinkaya F, et al
    Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.
    N Engl J Med. 2023;389:987-997.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.